Measles–Mumps–Rubella Vaccine

descriptionPublicationkeyboard_double_arrow_right Part of book or chapter of book , Other literature type 01 Jan 2017 English Publisher:Springer International Publishing

Authors: Timo Vesikari; Vytautas Usonis;

doi: 10.1007/978-3-030-77173-7_9 , 10.1007/978-3-319-59952-6_9

Measles–Mumps–Rubella Vaccine

- Summary
- Metrics

Abstract

The measles–mumps–rubella (MMR) vaccine is currently the exclusive tool for the prevention of measles, mumps, and rubella in Europe. The description below of single measles, mumps, and rubella vaccines is given for historical reasons and for the characterization of their properties as components of the MMR vaccine. Previous immunization programs with single vaccines, usually given as a single dose, were generally less effective than the current MMR immunization programs in early childhood, with the vaccine given in two doses.

Related Organizations

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average